{"cmr":"de-cm-kg/XETRA/FYB","since":null,"total":29,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-11-06","event_type":"ad_hoc","title":"Formycon AG recognizes non-cash impairments on FYB201 and FYB202 and revises its guidance for adjusted EBITDA | Ad-hoc - EQS News","category":"ad-hoc","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/ad-hoc/formycon-ag-recognizes-non-cash-impairments-on-fyb201-and-fyb202-and-revises-its-guidance-for-adjusted-ebitda/4d2113f0-7383-4cbf-8faa-56f7ee07ee9b_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hFWkyQTwf7z6tRmSJ7xw9KZ2bCB_EeWpUz4L5KsdY9yYUDFQzqpQ4Zmi7Rj522QoeGibToEjtGU4jQt-teINDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-11-06","event_type":"corporate_news","title":"Formycon maintains 2026 guidance for revenue, EBITDA and working capital, revises adjusted EBITDA and reassesses FYB201 and FYB202 | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-maintains-2026-guidance-for-revenue-ebitda-and-working-capital-revises-adjusted-ebitda-and-reassesses-fyb201-and-fyb202/2c519e61-a9c5-404b-9109-5fb74e2bf5db_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"N0LUDiQtjkGGo3RRz5Rg2aL0nFSCVktqGByx9OzgTvtrDjUrSvzxGmSIDjzUCoGTB8ffjqLbyw2cy7_W6Ma_Bg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-11-05","event_type":"ad_hoc","title":"Formycon AG recognizes non-cash impairments on FYB201 and FYB202 and revises its guidance for adjusted EBITDA | Ad-hoc - EQS News","category":"ad-hoc","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/ad-hoc/formycon-ag-recognizes-non-cash-impairments-on-fyb201-and-fyb202-and-revises-its-guidance-for-adjusted-ebitda/4d2113f0-7383-4cbf-8faa-56f7ee07ee9b_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EprQYAl9elgPDjvryfZm7fnGOnNU91LSbcFkhUhJ1aee6cJrT84yEwc3bNTv5qT1C7vYXw3FR_WBW6LIwhYQDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-11-05","event_type":"corporate_news","title":"Formycon invites to conference call on 2026 nine-month results and announces participation in international investor conferences | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-invites-to-conference-call-on-2026-nine-month-results-and-announces-participation-in-international-investor-conferences/a927ca43-7aec-4246-b5b0-f92779fc9c93_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Wf2Vxfij0UK7b6zGjgHWPm5rq_rQDZ9nl4an6chGja1TFDQSHUa0sHOR579LkN-QEFIv6rjm1RLDlVMlNewQDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-11-05","event_type":"corporate_news","title":"Formycon maintains 2026 guidance for revenue, EBITDA and working capital, revises adjusted EBITDA and reassesses FYB201 and FYB202 | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-maintains-2026-guidance-for-revenue-ebitda-and-working-capital-revises-adjusted-ebitda-and-reassesses-fyb201-and-fyb202/2c519e61-a9c5-404b-9109-5fb74e2bf5db_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"c4vYRE8RzWJt6atG7EhCzPf2Qsj2KTWyb3n2QnlXKVGz7HH8cfdq53R1ZhEgnEDDdQkn03eSNRNy7p4Zjz4_AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-11-05","event_type":"corporate_news","title":"Formycon lädt zur Telefonkonferenz zum Neunmonatsergebnis 2026 ein und gibt Teilnahme an internationalen Investorenkonferenzen bekannt | Corporate - EQS News","category":"corporate-news","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate-news/formycon-laedt-zur-telefonkonferenz-zum-neunmonatsergebnis-2026-ein-und-gibt-teilnahme-an-internationalen-investorenkonferenzen-bekannt/a927ca43-7aec-4246-b5b0-f92779fc9c93_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dQ5FFaiyd891HjYzEYraLAQ6cej30EC8hUpEFShhhkbrdsXfrstsLgOy-5auLcYmM6eWyRQAMhC1AgoeqjpVAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-11-05","event_type":"corporate_news","title":"Formycon hält die Prognose 2026 für Umsatz, EBITDA und ...","category":"corporate-news","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate-news/formycon-haelt-die-prognose-2026-fuer-umsatz-ebitda-und-working-capital-passt-das-bereinigte-ebitda-an-und-bewertet-fyb201-und-fyb202-neu/2c519e61-a9c5-404b-9109-5fb74e2bf5db_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"N2AU8pDwE7HKASWl8i7ygFxMYesHEHAYbYDFOeXHEezJGenj2URyKcLGSoz3Q_8kS0zHkYLZrrYD3URr6fEZCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-11-03","event_type":"corporate_news","title":"Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy | Research - EQS News","category":"research","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/research/original-research-formycon-ag-von-first-berlin-equity-research-gmbh-buy/11533c7a-24b8-40c8-931e-bc6eeb29b065_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PxAJ6h6oUlt8Km604KIlEW7u5cbaVwtdZAlLoB3paYVB0kxXKLRegrVflK-WFoc7hQD51kt_YkybBhVPuAQvAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-23","event_type":"corporate_news","title":"Formycon AG: Vorabbekanntmachung über die ...","category":"vorabbekanntmachung-finanzberichte","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/de/news/vorabbekanntmachung-finanzberichte/formycon-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-quartalsberichten-und-quartals-zwischenmitteilungen/ae715013-d828-4d89-90cc-127f6e362170_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gpqHmfNxCKB7g06ji41cnKZ82meYzKr4Nf815xNj2ICrl6YJ54przy3wz7A0CUaAUSTfqpkPjg82AxIeTaROAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-23","event_type":"corporate_news","title":"Formycon AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements | Advance financial reports - EQS News","category":"advance-financial-reports","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/advance-financial-reports/formycon-ag-preliminary-announcement-of-the-publication-of-quarterly-reports-and-quarterly-interim-statements/ae715013-d828-4d89-90cc-127f6e362170_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nvl2QcEn5KQoDHOrweA1HZXuTxCGv1NewAjgvRvB_x3AHDDXAaRdSu8oCa2CmJIvFB534Hw-BK4uP0phDJfgDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-23","event_type":"results","title":"Formycon AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | Vorabbekanntmachung Finanzberichte - EQS News","category":"vorabbekanntmachung-finanzberichte","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/de/news/vorabbekanntmachung-finanzberichte/formycon-ag-vorabbekanntmachung-ueber-die-veroeffentlichung-von-quartalsberichten-und-quartals-zwischenmitteilungen/ae715013-d828-4d89-90cc-127f6e362170_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XXZe6nA_Gpl_KAvQbwgVUz3eBtQAIkfZuEk3mOd7Ca_YXUI-wjbLb8-PAM7r_Q1-gkpvG297GnYRYnxMoD6bAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-21","event_type":"corporate_news","title":"Formycon and Biocelys Combine Complementary Development and Manufacturing Expertise in New Biosimilar Project FYB286 | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-and-biocelys-combine-complementary-development-and-manufacturing-expertise-in-new-biosimilar-project-fyb286/97effc29-5964-4f66-b238-90c3e880f439_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"26bn6bRLTT3n6CqYEr_d5gH53-iBG1hy4iOxzxxXkv9EnciONNMvU5LI1-7w8nhpcYCZrK5UZ6URYCwtkPNzCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-21","event_type":"corporate_news","title":"Formycon AG: Veröffentlichung gemäß § 111c AktG mit ...","category":"related-party-transactions","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/de/news/related-party-transactions/formycon-ag-veroeffentlichung-gemaess-c2a7-111c-aktg-mit-dem-ziel-der-europaweiten-verbreitung/3de098d5-ccf9-454d-9399-c0a814742b88_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"tUVBY-93lLEEbcUxliQuebLT6Nj60M77HLDHpUgwClBgFbCEF-e3_OUIKKejN9NunZorIN-EH3qMsxg3cIG4DA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-21","event_type":"corporate_news","title":"Formycon und Biocelys bündeln komplementäre Entwicklungs- und Herstellungskompetenzen im neuen Biosimilar-Projekt FYB286 | Corporate - EQS News","category":"corporate","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/de/news/corporate/formycon-und-biocelys-buendeln-komplementaere-entwicklungs-und-herstellungskompetenzen-im-neuen-biosimilar-projekt-fyb286/97effc29-5964-4f66-b238-90c3e880f439_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CAZ5xVUJr_yMJ36oED6OoXr-JpNU9wI0XzOGtjqBzN6zLwfxzhdEwV5AeWSkx07YVInS6KTNyat4wNuEu6qeCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-13","event_type":"corporate_news","title":"Formycon and Zydus: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by FDA | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-and-zydus-fyb206-becomes-first-publicly-announced-keytruda-biosimilar-accepted-for-review-by-fda/cd6aafe0-a73f-4d68-b838-b92c3d12b18e_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Vb6zFSpLs4kEsCCoZ2yBFi4nLsgKga5BmfbC8vqIzoxA9dwlCLXsDhcM0Uw2E_xiSt2l1iUKb1CTZRWBhEDFBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-12","event_type":"corporate_news","title":"Formycon und Zydus: FDA nimmt FYB206 als erstes ...","category":"corporate-news","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate-news/formycon-und-zydus-fda-nimmt-fyb206-als-erstes-oeffentlich-bekannt-gegebenes-keytruda-biosimilar-zur-pruefung-an/cd6aafe0-a73f-4d68-b838-b92c3d12b18e_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hxMzv4yE1IHQHxiDW89mgEJ_saMiDMvex15MQw7WZ4a9Gzk0jR1yQRKHkrKLId5IiTnizcA1skuB6UenfXJ8Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-06","event_type":"corporate_news","title":"Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-optimizes-biosimilar-development-with-ai-powered-technologies-digital-solutions-enhance-development-efficiency-as-part-of-the-fyb4growth-strategy/c2674e4e-faa0-46f9-b2a4-f7669eaef518_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4twwkJxz5JK9NbxfEv-WDJlj11WsV_zgqB7UCXJtdnPHlf3-5LEr4vaUKeOhYQZtFsN1dGqSypoGdZLbfVAECg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-10-06","event_type":"corporate_news","title":"Formycon optimiert Biosimilar-Entwicklung mit KI-gestützten Technologien: Digitale Lösungen steigern die Entwicklungseffizienz im Rahmen der FYB4GROWTH-Strategie | Corporate - EQS News","category":"corporate-news","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate-news/formycon-optimiert-biosimilar-entwicklung-mit-ki-gestuetzten-technologien-digitale-loesungen-steigern-die-entwicklungseffizienz-im-rahmen-der-fyb4growth-strategie/c2674e4e-faa0-46f9-b2a4-f7669eaef518_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9bHcNeBNR1Y4oGUQH-wLjnP-KN2G5OlYe4wqK7y3JCgSphTgt276CPoQmkYEV5fQ4INqV26J0ElBna-V0kxFBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-08-05","event_type":"corporate_news","title":"Formycon invites to conference call on 2026 half-year results and announces participation in international investor conferences | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-invites-to-conference-call-on-2026-half-year-results-and-announces-participation-in-international-investor-conferences/5af7aea9-cbfa-47c8-9024-1d2d95f64a7c_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-dDhv2DYgi12jglNNk6OjM9NPp0uF_jjVR3zGY2cAcpPgKyPUCAU_RUCwh2wrOZynNsrMBmqjGC6PFj_6hn5AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-08-05","event_type":"results","title":"Formycon invites to conference call on 2026 half-year results and ...","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-invites-to-conference-call-on-2026-half-year-results-and-announces-participation-in-international-investor-conferences/5af7aea9-cbfa-47c8-9024-1d2d95f64a7c_en","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"i1kpSGBX-ar8v1tSYbCeUuTaVkZc2YTISAipJrKmE8wIBl07YNhYTO_uYShX1a3q4BfBxIuqQorU5nt1-EDCAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-05-19","event_type":"corporate_news","title":"Formycon expands commercial portfolio: Aflibercept biosimilars Ahzantive® and Baiama® are now available in the European Union | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-expands-commercial-portfolio-aflibercept-biosimilars-ahzantive-and-baiama-are-now-available-in-the-european-union/6af3b82a-7ebb-4d7b-bab6-5dc1d9364ca5_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Lc3gqcYSHCUaLTwvJjoJtP-kCM5Zo_C7M3uAdjdD_tL4JGYR8M1YF8pAVq_9zG64vPa7GiCLwlBJx8LiVEt3Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-03-19","event_type":"corporate_news","title":"Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-secures-license-date-for-aflibercept-2-mg-biosimilar-fyb203-in-europe-and-further-territories-following-settlement-with-regeneron-and-bayer/272a0e79-6079-4c7c-8f6d-f00d0994a372_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ErW20gymJbontaRtYVJx4Qu3EuWPjSskfXm90WfebH1R7BabVxTka9MHh2onJrX_dPp7B_XUSevOmvgo8oGvBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2026-03-19","event_type":"newswire_release","title":"Formycon secures license date for aflibercept 2 mg biosimilar ...","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-secures-license-date-for-aflibercept-2-mg-biosimilar-fyb203-in-europe-and-further-territories-following-settlement-with-regeneron-and-bayer/272a0e79-6079-4c7c-8f6d-f00d0994a372_en","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"H93x7UAT-S91qknB5cfTLfthoctIIJ1yiHqtJR6T65v0v1env7FHb-FTGTYlXyadscwScYD1p-WCnjWgg6dGAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2025-12-09","event_type":"newswire_release","title":"Formycon and Zydus partner for exclusive licensing and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/fr/news-release/2025/12/09/3202239/0/en/Formycon-and-Zydus-partner-for-exclusive-licensing-and-supply-agreement-of-FYB206-a-biosimilar-to-Keytruda-Pembrolizumab-in-the-U-S-and-Canada.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"vxG9SZ78nvJ4uj-gmZT-905Nonn9HfdJG2dZdZyxb6Elm-vnW44m-F35eqNRhVYaEbSHZjX5UA8GjZBijsNrBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2025-12-09","event_type":"newswire_release","title":"Formycon and Zydus partner for exclusive licensing and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/09/3202239/0/en/Formycon-and-Zydus-partner-for-exclusive-licensing-and-supply-agreement-of-FYB206-a-biosimilar-to-Keytruda-Pembrolizumab-in-the-U-S-and-Canada.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PWj83x_lzj_b5OfY5ZFheDZL2W0xraJmQy5mbbA7OU1_4tGJvreEhpGrAmy_-BQxhWZO3RvaHLptGcTOYq-OCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2025-12-09","event_type":"newswire_release","title":"Formycon and Zydus partner for exclusive licensing and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/de/news-release/2025/12/09/3202239/0/en/Formycon-and-Zydus-partner-for-exclusive-licensing-and-supply-agreement-of-FYB206-a-biosimilar-to-Keytruda-Pembrolizumab-in-the-U-S-and-Canada.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2kGCgIrZKGzn5wGX407w9RJWQPW65DB7uhfwu8Ema4H9jU_cJvIwziK5L8Si3C0TJuNSJQ3J1l-WtstukEKWBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2025-11-24","event_type":"newswire_release","title":"NTC diventa partner commerciale di Formycon per la distribuzione ...","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/it/comunicati-stampa/ntc-diventa-partner-commerciale-di-formycon-per-la-distribuzione-in-italia-di-fyb203baiama-302623227.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"t_NPxxIFZRvWDwv-y7apycE62EP7BN49IReUHEm7ohnrFuplOWqTRLqPtIxzjWsoInGXYcqsrwDycvg400csCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2025-10-30","event_type":"corporate_news","title":"Formycon lädt zur Telefonkonferenz zum Neunmonatsergebnis 2025 ein und gibt Teilnahme an Investorenkonferenzen im 4. Quartal 2025 bekannt | Corporate - EQS News","category":"corporate","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-laedt-zur-telefonkonferenz-zum-neunmonatsergebnis-2025-ein-und-gibt-teilnahme-an-investorenkonferenzen-im-4-quartal-2025-bekannt/3a5364ef-7edb-4959-9154-71fba59818c5_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DlCQgI-LcIbcUd0usJXT4xMXydPtPt-TuQjw9NGUGmiS_5ii-dJlLGrZXQ4EFEA3_e0JVqCfjJeEMlG105mpCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/FYB","date":"2025-10-30","event_type":"newswire_release","title":"Formycon lädt zur Telefonkonferenz zum Neunmonatsergebnis ...","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/formycon-laedt-zur-telefonkonferenz-zum-neunmonatsergebnis-2025-ein-und-gibt-teilnahme-an-investorenkonferenzen-im-4-quartal-2025-bekannt/3a5364ef-7edb-4959-9154-71fba59818c5_de","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4R3xBcvGNN6hAopVh1E8DWVUYzqTQqhcudwirrJA9VjBPGbfNxp2fPyj0lVUikUdugNUmgxPCpaCttG0rucBBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}